You See the Foot First.
Own the Diagnosis.
Most Peripheral Artery Disease (PAD) patients walk into your office without a single symptom. Start PAD testing for podiatry — before it becomes amputation.
Most Peripheral Artery Disease (PAD) patients walk into your office without a single symptom. Start PAD testing for podiatry — before it becomes amputation.

You already manage wounds. You already treat diabetics. You already see the at-risk foot every single day.
The question is — are you testing for ischemia?
When PAD goes undetected, infection sets in, wounds fail to heal, and amputation becomes the only option. Early vascular assessment changes that trajectory entirely.
CMS reimburses podiatrists for in-office vascular studies. The math is clear — and the payback period is short.
Use the slider to see projected annual revenue based on your expected study volume.

Podiatrists don't need to add a new service line. You need to capture the vascular care you're already accountable for.
Ischemia is silent until it's catastrophic. In-office testing lets you detect PAD at the stage when intervention still makes a difference — before wounds fail and infection sets in.
Walk into every vascular referral with objective ABI/TBI data in hand. Documented results elevate your clinical credibility and the urgency of your referral.
The podiatrist who tests becomes the hub of the patient's wound and vascular care — better outcomes for patients, and a stronger, more differentiated practice.
No. Most clinical staff are fully proficient after brief onboarding. The system is designed for non-vascular offices — no vascular testing background required.
No. The exam takes approximately 10 minutes and is fully delegated to your existing staff while you continue seeing patients.
Standard ABI can be unreliable in diabetics with medial arterial calcification. The simpleABI-400CL’s ABI-Q™ technology uses PVR waveform analysis, which remains accurate even when standard ankle pressures are falsely elevated.
Yes. CPT codes 93922 and 93923 are reimbursed by Medicare and most commercial payers when medically indicated — which describes the majority of your diabetic and at-risk patients.
Disclaimer: Reimbursement varies by payer and requires medical necessity. Contact your payer for specific coverage and payment details. Newman Medical makes no guarantee of reimbursement. Data based on Medicare Fee Schedules, Part B Contractors, 2023.
Based on CMS national averages, just 3 studies per week generates enough reimbursement to cover the system in under 6 months. Most practices exceed that volume within their first month of use.
No. The simpleABI-400CL fits into any standard exam room on a mobile cart. No dedicated space, no plumbing, and no special electrical requirements.
A quick, no-pressure demo. We'll walk you through the workflow, show you real results, and work through the revenue math for your specific practice.
Schedule My Free Demo